PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
51.63%
Positive growth while JHX shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
51.63%
Positive growth while JHX shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.63%
EBITDA growth below 50% of JHX's 139.32%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
51.63%
Operating income growth below 50% of JHX's 123.19%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth while JHX reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-114.00%
Tax expense reduction while JHX shows 78.29% growth. Joel Greenblatt would examine advantage.
114.00%
Net income growth exceeding 1.5x JHX's 43.58%. David Dodd would verify competitive advantages.
41.13%
Net margin growth 50-75% of JHX's 55.00%. Martin Whitman would scrutinize operations.
100.00%
EPS growth exceeding 1.5x JHX's 50.00%. David Dodd would verify competitive advantages.
100.00%
Diluted EPS growth exceeding 1.5x JHX's 51.06%. David Dodd would verify competitive advantages.
7.00%
Share count increase while JHX reduces shares. John Neff would investigate differences.
7.00%
Diluted share reduction below 50% of JHX's 0.12%. Michael Burry would check for concerns.